» Articles » PMID: 30690449

Influenza-Associated Outcomes Among Pregnant, Postpartum, and Nonpregnant Women of Reproductive Age

Overview
Journal J Infect Dis
Date 2019 Jan 29
PMID 30690449
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pregnant women are prioritized for seasonal influenza vaccination, but the evidence on the risk of influenza during pregnancy that is used to inform these policies is limited.

Methods: Individual-level administrative data sets and active surveillance data were joined to estimate influenza-associated hospitalization and outpatient visit rates by pregnancy, postpartum, and trimester status.

Results: During 2012-2015, 46 of 260 (17.7%) influenza-confirmed hospitalizations for acute respiratory infection and 13 of 294 (4.4%) influenza-confirmed outpatient visits were among pregnant and postpartum women. Pregnant and postpartum women experienced higher rates of influenza-associated hospitalization than nonpregnant women overall (rate ratio [RR], 3.4; 95% confidence interval [CI], 2.5-4.7) and by trimester (first, 2.5 [95% CI, 1.2-5.4]; second, 3.9 [95% CI, 2.4-6.3]; and third, 4.8 [95% CI, 3.0-7.7]); the RR for the postpartum period was 0.7 (95% CI, 3.0-7.7). Influenza A viruses were associated with an increased risk (RR for 2009 pandemic influenza A[H1N1] virus, 5.3 [95% CI, 3.2-8.7]; RR for influenza A(H3N2) virus, 3.0 [95% CI, 1.8-5.0]), but influenza B virus was not (RR, 1.8; 95% CI, .7-4.6). Influenza-associated hospitalization rates in pregnancy were significantly higher for Māori women (RR, 3.2; 95% CI, 1.3-8.4), compared with women of European or other ethnicity. Similar risks for influenza-confirmed outpatient visits were not observed.

Conclusion: Seasonal influenza poses higher risks of hospitalization among pregnant women in all trimesters, compared with nonpregnant women. Hospitalization rates vary by influenza virus type and ethnicity among pregnant women.

Citing Articles

Vaccine Acceptance Among Pregnant Women in Israel During COVID-19: Influences and Decision-Making Factors.

Feldman N, Bitan M, Alayev M, Tal O Vaccines (Basel). 2025; 12(12.

PMID: 39772065 PMC: 11680311. DOI: 10.3390/vaccines12121404.


Defining the balance between optimal immunity and immunopathology in influenza virus infection.

Nguyen T, Rowntree L, Chua B, Thwaites R, Kedzierska K Nat Rev Immunol. 2024; 24(10):720-735.

PMID: 38698083 DOI: 10.1038/s41577-024-01029-1.


Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes.

Daley M, Reifler L, Shoup J, Glanz J, Naleway A, Nelson J Prev Med. 2023; 177:107751.

PMID: 37926397 PMC: 10881081. DOI: 10.1016/j.ypmed.2023.107751.


Influenza-associated hospitalisation and mortality rates among global Indigenous populations; a systematic review and meta-analysis.

Betts J, Weinman A, Oliver J, Braddick M, Huang S, Nguyen M PLOS Glob Public Health. 2023; 3(4):e0001294.

PMID: 37053124 PMC: 10101428. DOI: 10.1371/journal.pgph.0001294.


High Expression Level of α2-3-Linked Sialic Acids on Salivary Glycoproteins of Breastfeeding Women May Help to Protect Them from Avian Influenza Virus Infection.

Ding L, Cheng Y, Guo W, Sun S, Chen X, Zhang T Molecules. 2022; 27(13).

PMID: 35807530 PMC: 9268398. DOI: 10.3390/molecules27134285.